#United States #biotechnology #CARY #Heron Therapeutics #Cary NC

Heron Therapeutics Relocates Headquarters

Heron Therapeutics, Inc. (Nasdaq: HRTX), a biotech firm known for its commercial-stage innovations, has officially announced the relocation of its corporate headquarters from San Diego, California, to Cary, North Carolina, effective January 1, 2025. This strategic shift is designed to enhance operational efficiencies and further strengthen the company's presence in the thriving biotech community of the Research Triangle Park (RTP) area, widely regarded as a major hub for high-tech research and development.

The decision to move was influenced by the growing need for expanded space and resources, given the increasing scale of operations and employee count at Heron. Currently, a significant portion of the management team and corporate employees is already based in Cary, making this transition a natural step in optimizing corporate functions.

Craig Collard, the CEO of Heron, expressed enthusiasm about the upcoming move, stating, "We are excited to move our headquarters to Cary, North Carolina, which represents a significant milestone in Heron’s journey. This move will not only strengthen our ability to support our employees by centralizing our operations and resources but also positions us in an excellent location from which we can continue making strategic partnerships as we grow our existing portfolio focused on improving the lives of patients in the acute and oncology care settings."

The new office will be located at 100 Regency Forest Drive, Suite 300, Cary, NC 27518. This location will benefit from proximity to leading research facilities and a network of innovative companies, creating opportunities for collaboration and growth in the biotech sector.

Heron Therapeutics is dedicated to enhancing patient care through the development and commercialization of groundbreaking therapeutic innovations. With a focus on the acute care and oncology fields, Heron aims to elevate the standard of care through its advanced scientific methodologies and patented technology.

By relocating to Cary, the company not only affirms its commitment to providing improved medical solutions but also aligns with its mission to foster innovation within a supportive and thriving community.

Forward-Looking Statements

In line with this announcement, Heron issued a caveat regarding forward-looking statements. These declarations are based on management’s expectations and assumptions as of the release date and are susceptible to various risks that could yield actual results that differ materially. Therefore, stakeholders are advised to consider these risks as highlighted in the company's recent Annual Report and other relevant filings.

As Heron Therapeutics embarks on this new chapter in a promising locale, the biotech community and stakeholders alike can expect significant advancements in patient therapies and corporate collaborations moving forward. This transition underscores the company's strategic vision and determination to elevate the quality of life for patients through innovative medical solutions.

For further information, visit Heron Therapeutics' official website.